Managers / Q3 2022 · view latest →
LASRY MARC
CIK 0001259927
Summary
Lasry Marc reported $52M in U.S.-listed holdings across 14 positions for Q3 2022.
The portfolio is heavily concentrated: AMPY alone accounts for 32.4% of reported value.
The book was largely unchanged from Q2 2022.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 53.4% · $28M
- US DOMESTIC · 29.4% · $15M
- REIT · 15.5% · $8M
- Other · 0.8% · $440,000
- PUBLIC · 0.7% · $384,000
Quarter-over-Quarter Changes full breakdown →
vs Q2 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| RANIRANI THERAPEUTICS HLDGS INC | HELD | +59 | 62.9K | −$47,000 | $602,000 |
| PARAMOUNT GLOBAL | HELD | +0 | 214.6K | −$8M | $8,000 |
| FORGE GLOBAL HOLDINGS INC | HELD | +0 | 251.5K | −$2M | $440,000 |
| IMPEL PHARMACEUTICALS INC | HELD | +0 | 408.3K | −$2M | $2M |
| REALOGY GRP LLC/REALOGY CO | HELD | +0 | 18.50M | −$546,000 | $13M |
| ALXALEXANDERS INC | HELD | +0 | 38.7K | −$510,000 | $8M |
| CHEFS WHSE INC | HELD | +0 | 1.35M | −$169,000 | $1M |
| EXELA TECHNOLOGIES INC | HELD | +0 | 77.5K | −$166,000 | $376,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | AMPYAMPLIFY ENERGY CORP NEWhistory → | COM | 32.36% | $17M | 2.56M |
| 2 | REALOGY GRP LLC/REALOGY CO | NOTE 0.250% 6/1 | 24.83% | $13M | 18.50M |
| 3 | FYBRFRONTIER COMMUNICATIONS PAREhistory → | COM | 16.10% | $8M | 357.5K |
| 4 | ALXALEXANDERS INChistory → | COM | 15.53% | $8M | 38.7K |
| 5 | IMPEL PHARMACEUTICALS INC | COM | 3.82% | $2M | 408.3K |
| 6 | CHEFS WHSE INC | NOTE 1.875%12/0 | 2.55% | $1M | 1.35M |
| 7 | MAGNITE INC | NOTE 0.250% 3/1 | 2.07% | $1M | 1.45M |
| 8 | RANIRANI THERAPEUTICS HLDGS INChistory → | COM CL A | 1.16% | $602,000 | 62.9K |
| 9 | FORGE GLOBAL HOLDINGS INC | COM | 0.85% | $440,000 | 251.5K |
| 10 | EXELA TECHNOLOGIES INC | 6% CONV PFD SR B | 0.72% | $376,000 | 77.5K |
| 11 | PARAMOUNT GLOBAL | 5.75% CONV PFD A | 0.02% | $8,000 | 214.6K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2025 | $15M | 9 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $18M | 8 | Aug 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $22M | 10 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $23M | 11 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $55M | 10 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $101M | 11 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $117M | 11 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $68M | 10 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $101M | 13 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $77M | 12 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $52M | 10 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $64M | 11 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $52M | 14 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $66M | 14 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $201M | 16 | May 17, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $203M | 11 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $162M | 11 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $217M | 16 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $145M | 11 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $263M | 11 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $155M | 6 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $152M | 9 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $122M | 11 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $298M | 11 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $306M | 15 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $466M | 17 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $557M | 16 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $454M | 13 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 4 additional managers.
- Avenue Capital Management II GenPar, LLC028-12377
- Avenue Capital Management II, L.P.028-11224
- Avenue Energy Opportunities Partners II, LLC028-22561
- GL Energy Opportunities Partners II, LLC028-22562
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.